COM:RVLPHARMA
RVL Pharmaceuticals
- Stock
Last Close
0.04
20/10 20:00
Market Cap
3.14M
Beta: -
Volume Today
63.96M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|
net income | -41.82M - | -45.15M 7.97% | -109.68M 142.90% | -270.90M 146.99% | -79.59M 70.62% | -64.92M 18.43% | -51.69M 20.38% | |
depreciation and amortization | 23.59M - | 46.45M 96.95% | 81.57M 75.61% | 57.02M 30.11% | 21.03M 63.12% | 8.18M 61.12% | 375K 95.41% | |
deferred income tax | -13.16M - | -44.49M 238.04% | -15.51M 65.13% | -26.79M 72.71% | -1.16M 95.69% | -194K 83.22% | -90K 53.61% | |
stock based compensation | 25.54M - | 73.82M 188.99% | 1.97M 97.34% | 4.93M 150.95% | 4.92M 0.14% | 7.59M 54.19% | 4.07M 46.41% | |
change in working capital | -46.33M - | 9.49M 120.48% | -25.86M 372.55% | -15.78M 38.98% | -1.86M 88.23% | -7.46M 301.88% | 4.39M 158.78% | |
accounts receivables | -12.53M - | 5.27M 142.06% | -17.04M 423.43% | 12.67M 174.37% | 17.50M 38.05% | 7.11M 59.37% | -898K 112.63% | |
inventory | 12.56M - | 2.89M 76.98% | -7.44M 357.12% | 3.08M 141.39% | 3.37M 9.52% | 2.60M 23.02% | 54K 97.92% | |
accounts payables | -14.39M - | 588.24K 104.09% | -11.33M 2,025.35% | -16.38M 44.58% | -1.72M 89.48% | -134K 92.22% | -1.37M 922.39% | |
other working capital | -31.97M - | 737.37K 102.31% | 9.95M 1,248.96% | -15.15M 252.36% | -21.00M 38.57% | -17.03M 18.90% | 6.60M 138.76% | |
other non cash items | 32.93M - | 91.55M 177.98% | 105.07M 14.77% | 285.09M 171.33% | 74.24M 73.96% | 2.08M 97.20% | 5.14M 147.59% | |
net cash provided by operating activities | -44.79M - | 57.84M 229.13% | 37.56M 35.06% | 33.57M 10.63% | 17.59M 47.60% | -54.73M 411.15% | -37.81M 30.92% | |
investments in property plant and equipment | -15.93M - | -6.90M 56.72% | -4.14M 39.91% | -4.04M 2.58% | -3.13M 22.37% | -1.78M 43.14% | -752K 57.80% | |
acquisitions net | -321M - | |||||||
purchases of investments | ||||||||
sales maturities of investments | ||||||||
other investing activites | -118.53M - | -12.50M 89.45% | 10K 100.08% | 17K 70% | 50K 194.12% | 118.23M 236,370.00% | 878K 99.26% | |
net cash used for investing activites | -453.46M - | -19.40M 95.72% | -4.13M 78.69% | -4.02M 2.75% | -3.08M 23.28% | 116.45M 3,876.04% | 126K 99.89% | |
debt repayment | -4.26M - | -338.87M 7,848.12% | -57.22M 83.11% | -3.22M 94.38% | -50.13M 1,457.71% | -222.31M 343.49% | -2.71M 98.78% | |
common stock issued | 58.08M - | 62.44M - | 32.41M 48.09% | 23.63M 27.09% | ||||
common stock repurchased | -2.79M - | -8.10M 190.67% | ||||||
dividends paid | -23.31M - | -219K - | ||||||
other financing activites | 448.09M - | 315.56M 29.58% | 2.74M 99.13% | 1.31M 52.09% | -311K 123.67% | 54.56M 17,644.05% | 20.86M 61.77% | |
net cash used provided by financing activities | 420.52M - | -23.31M 105.54% | 3.60M 115.46% | -4.69M 230.15% | 3.68M 178.49% | -135.33M 3,775.45% | 41.78M 130.87% | |
effect of forex changes on cash | -316.13K - | 57.24K 118.11% | -937.68K 1,738.24% | 175K 118.66% | ||||
net change in cash | -78.05M - | 15.18M 119.45% | 36.09M 137.68% | 25.03M 30.65% | 18.19M 27.34% | -73.61M 504.71% | 4.10M 105.57% | |
cash at beginning of period | 97.61M - | 19.56M 79.96% | 34.74M 77.64% | 70.83M 103.88% | 95.86M 35.34% | 114.05M 18.97% | 40.44M 64.54% | |
cash at end of period | 19.56M - | 34.74M 77.64% | 70.83M 103.88% | 95.86M 35.34% | 114.05M 18.97% | 40.44M 64.54% | 44.54M 10.14% | |
operating cash flow | -44.79M - | 57.84M 229.13% | 37.56M 35.06% | 33.57M 10.63% | 17.59M 47.60% | -54.73M 411.15% | -37.81M 30.92% | |
capital expenditure | -15.93M - | -6.90M 56.72% | -4.14M 39.91% | -4.04M 2.58% | -3.13M 22.37% | -1.78M 43.14% | -752K 57.80% | |
free cash flow | -60.72M - | 50.94M 183.89% | 33.41M 34.41% | 29.53M 11.63% | 14.46M 51.05% | -56.51M 490.94% | -38.56M 31.77% |
All numbers in (except ratios and percentages)